Showing results (431-440 of 460) with videos related to

Sort By:
Pageof 46
Nature Medicine|March 21, 1998
Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: implications for antiviral therapyG Pantaleo, O J Cohen, T Schacker, et al.
AIDS (London, England)|February 1, 1988
Genital ulceration as a risk factor for human immunodeficiency virus infectionR M Greenblatt, S A Lukehart, F A Plummer, et al.
Clinical Transplantation|March 18, 2014
Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantationRebecca L Corey, Michael D Whitaker, Michael D Crowell, et al.
AIDS Research and Human Retroviruses|February 24, 1999
HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation GroupG J Gorse, L Corey, G B Patel, et al.
British Journal of Sports Medicine|December 19, 2019
Are we missing the target? Are we aiming too low? What are the aerobic exercise prescriptions and their effects on markers of cardiovascular health and systemic inflammation in patients with knee osteoarthritis? A systematic review and meta-analysisJenna M Schulz, Trevor B Birmingham, Hayden F Atkinson, et al.
The Journal of Infectious Diseases|February 18, 1998
Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and bloodR W Coombs, C E Speck, J P Hughes, et al.
Journal of Clinical Microbiology|April 16, 1999
Multicenter comparison of PCR assays for detection of human herpesvirus 8 DNA in semenP E Pellett, T J Spira, O Bagasra, et al.
Annals of Internal Medicine|October 15, 1993
Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infectionA C Collier, R W Coombs, M A Fischl, et al.
AIDS Research and Human Retroviruses|May 20, 1996
Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation GroupM C Keefer, B S Graham, M J McElrath, et al.
The American Journal of Medicine|July 20, 1982
Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infectionsL Corey, J K Benedetti, C W Critchlow, et al.
Pageof 46